Anti-SPP24/ SPP2/ SPP-244 functional antibody

Anti-SPP24/ SPP2/ SPP-244 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SPP2/SPP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1319-Ab-1/ GM-Tg-hg-SE1319-Ab-2Anti-Human SPP2 monoclonal antibodyHuman
GM-Tg-rg-SE1319-Ab-1/ GM-Tg-rg-SE1319-Ab-2Anti-Rat SPP2 monoclonal antibodyRat
GM-Tg-mg-SE1319-Ab-1/ GM-Tg-mg-SE1319-Ab-2Anti-Mouse SPP2 monoclonal antibodyMouse
GM-Tg-cynog-SE1319-Ab-1/ GM-Tg-cynog-SE1319-Ab-2Anti-Cynomolgus/ Rhesus macaque SPP2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1319-Ab-1/ GM-Tg-felg-SE1319-Ab-2Anti-Feline SPP2 monoclonal antibodyFeline
GM-Tg-cang-SE1319-Ab-1/ GM-Tg-cang-SE1319-Ab-2Anti-Canine SPP2 monoclonal antibodyCanine
GM-Tg-bovg-SE1319-Ab-1/ GM-Tg-bovg-SE1319-Ab-2Anti-Bovine SPP2 monoclonal antibodyBovine
GM-Tg-equg-SE1319-Ab-1/ GM-Tg-equg-SE1319-Ab-2Anti-Equine SPP2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1319-Ab-1/ GM-Tg-hg-SE1319-Ab-2; GM-Tg-rg-SE1319-Ab-1/ GM-Tg-rg-SE1319-Ab-2;
GM-Tg-mg-SE1319-Ab-1/ GM-Tg-mg-SE1319-Ab-2; GM-Tg-cynog-SE1319-Ab-1/ GM-Tg-cynog-SE1319-Ab-2;
GM-Tg-felg-SE1319-Ab-1/ GM-Tg-felg-SE1319-Ab-2; GM-Tg-cang-SE1319-Ab-1/ GM-Tg-cang-SE1319-Ab-2;
GM-Tg-bovg-SE1319-Ab-1/ GM-Tg-bovg-SE1319-Ab-2; GM-Tg-equg-SE1319-Ab-1/ GM-Tg-equg-SE1319-Ab-2
Products NameAnti-SPP2 monoclonal antibody
Formatmab
Target NameSPP2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SPP2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1319-Ag-1Recombinant multi-species SPP24/ SPP2/ SPP-244 protein
    ORF Viral VectorpGMLP005151human SPP2 Lentivirus plasmid
    ORF Viral VectorvGMLP005151human SPP2 Lentivirus particle
    ORF Viral VectorpGMLPm003819mouse Spp2 Lentivirus plasmid
    ORF Viral VectorvGMLPm003819mouse Spp2 Lentivirus particle


    Target information

    Target IDGM-SE1319
    Target NameSPP2
    Gene ID6694,75396,94168,718239,610394,101101496,281500,100065471
    Gene Symbol and Synonyms0610038O04Rik,pp-24,SPP-24,SPP2,SPP24
    Uniprot AccessionQ13103,Q62740,Q27967
    Uniprot Entry NameSPP24_HUMAN,SPP24_RAT,SPP24_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseOvary Cancer
    Gene EnsemblENSG00000072080
    Target ClassificationN/A

    The target: SPP2, gene name: SPP2, also named as SPP-244, SPP2. This gene encodes a secreted phosphoprotein that is a member of the cystatin superfamily. [provided by RefSeq, Oct 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.